BioMarin Pharmaceuticals
BMRN
BMRN
391 hedge funds and large institutions have $12.4B invested in BioMarin Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 163 increasing their positions, 120 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 13 → 13 (0)
7% less capital invested
Capital invested by funds: $13.3B → $12.4B (-$906M)
Holders
391
Holding in Top 10
13
Calls
$102M
Puts
$87.3M
Top Buyers
| 1 | +$71.8M | |
| 2 | +$63M | |
| 3 | +$58.4M | |
| 4 |
IG
ING Group
Amsterdam,
Netherlands
|
+$57.4M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$44.4M |
Top Sellers
| 1 | -$240M | |
| 2 | -$210M | |
| 3 | -$186M | |
| 4 |
JP Morgan Chase
New York
|
-$86.4M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$77.4M |